Amphastar Pharmaceuticals Inc (AMPH) USD0.0001

Sell:$24.15Buy:$24.20$0.12 (0.50%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$24.15
Buy:$24.20
Change:$0.12 (0.50%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$24.15
Buy:$24.20
Change:$0.12 (0.50%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Key people

Mary Ziping Luo
Chairman of the Board, Chief Operating Officer, Chief Scientist
Jack Yongfeng Zhang
President, Chief Executive Officer, Chief Scientific Officer, Director
William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Jacob Liawatidewi
Executive Vice President of Sales and Marketing, Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S, Company Secretary, Director
Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Richard K. Prins
Lead Independent Director
Gayle Deflin
Independent Director
Diane G. Gerst
Independent Director
Howard S. Lee
Independent Director
Floyd F. Petersen
Independent Director
Click to see more

Key facts

  • EPIC
    AMPH
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US03209R1032
  • Market cap
    $1.15bn
  • Employees
    2,028
  • Shares in issue
    60.73m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.